glp-1 receptor agonist side effects agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Glucagon-like Receptor-1 agonists for obesity:

Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis

Ethics declarations Competing interests M.N

Step 3: Support with Vitamin C Vitamin C and glutathione are partners in the body

Also, these effects can be attributed to direct action on GLP-1R in cardiac and vascular tissues [50]

6) Pro-Regenerative Crosstalk Human-centric reviews 9 detail how IGF-1 interacts with cytokines (e.g., IL-6) and niche signals to regulate repair dynamics, offering a systems-level explanation for why restoring IGF-1 signaling aligns with better recovery trajectories